MENU
KOD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kodiak Sciences (KOD) Earnings Date & Reports

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

KOD is expected to report earnings to rise 2.91% to -105 cents per share on November 12

Kodiak Sciences KOD Stock Earnings Reports
Q3'25
Est.
$-1.06
Q2'25
Beat
by $0.01
Q1'25
Beat
by $2.14
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.06
The last earnings report on August 13 showed earnings per share of -102 cents, beating the estimate of -103 cents. With 12.56K shares outstanding, the current market capitalization sits at 500.22M.
View a ticker or compare two or three
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KOD showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of retinal disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1200 Page Mill Road
Phone
+1 650 281-0850
Employees
111
Web
https://www.kodiak.com